| Lebrikizumab treatment in adults with asthma J Corren, RF Lemanske Jr, NA Hanania, PE Korenblat, MV Parsey, ... New England Journal of Medicine 365 (12), 1088-1098, 2011 | 1906 | 2011 |
| Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of … A Qaseem, TJ Wilt, SE Weinberger, NA Hanania, G Criner, ... Annals of internal medicine 155 (3), 179-191, 2011 | 1418 | 2011 |
| Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study NA Hanania, S Wenzel, K Rosén, HJ Hsieh, S Mosesova, DF Choy, P Lal, ... American journal of respiratory and critical care medicine 187 (8), 804-811, 2013 | 1065 | 2013 |
| Anxiety and depression in COPD: current understanding, unanswered questions, and research needs J Maurer, V Rebbapragada, S Borson, R Goldstein, ME Kunik, ... Chest 134 (4), 43S-56S, 2008 | 1038 | 2008 |
| Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial NA Hanania, O Alpan, DL Hamilos, JJ Condemi, I Reyes-Rivera, J Zhu, ... Annals of internal medicine 154 (9), 573-582, 2011 | 686 | 2011 |
| Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes MLK Han, EA Kazerooni, DA Lynch, LX Liu, S Murray, JL Curtis, GJ Criner, ... Radiology 261 (1), 274-282, 2011 | 533 | 2011 |
| Radiation-induced lung injury: assessment and management AN Hanania, W Mainwaring, YT Ghebre, NA Hanania, M Ludwig Chest 156 (1), 150-162, 2019 | 519 | 2019 |
| Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials NA Hanania, P Korenblat, KR Chapman, ED Bateman, P Kopecky, ... The Lancet Respiratory Medicine 4 (10), 781-796, 2016 | 492 | 2016 |
| Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort NA Hanania, H Müllerova, NW Locantore, J Vestbo, ML Watkins, ... American journal of respiratory and critical care medicine 183 (5), 604-611, 2011 | 488 | 2011 |
| The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the Diskus inhaler for the treatment of COPD NA Hanania, P Darken, D Horstman, C Reisner, B Lee, S Davis, T Shah Chest 124 (3), 834-843, 2003 | 476 | 2003 |
| Revisiting T ype 2‐high and T ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications D Robinson, M Humbert, R Buhl, AA Cruz, H Inoue, S Korom, NA Hanania, ... Clinical & Experimental Allergy 47 (2), 161-175, 2017 | 457 | 2017 |
| Efficacy of esomeprazole for treatment of poorly controlled asthma American Lung Association Asthma Clinical Research Centers New England Journal of Medicine 360 (15), 1487-1499, 2009 | 447 | 2009 |
| Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies NA Hanania, M Noonan, J Corren, P Korenblat, Y Zheng, SK Fischer, ... Thorax 70 (8), 748-756, 2015 | 429 | 2015 |
| Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ... Chest 147 (4), 999-1007, 2015 | 420 | 2015 |
| Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma ME Wechsler, M Laviolette, AS Rubin, J Fiterman, JRL e Silva, PL Shah, ... Journal of allergy and clinical immunology 132 (6), 1295-1302. e3, 2013 | 404 | 2013 |
| Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised … MT Dransfield, J Bourbeau, PW Jones, NA Hanania, DA Mahler, J Vestbo, ... The Lancet Respiratory Medicine 1 (3), 210-223, 2013 | 403 | 2013 |
| Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the … I Agache, J Beltran, C Akdis, M Akdis, C Canelo‐Aybar, GW Canonica, ... Allergy 75 (5), 1023-1042, 2020 | 383 | 2020 |
| Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers NA Hanania, R Wittman, S Kesten, KR Chapman Chest 105 (1), 111-116, 1994 | 383 | 1994 |
| Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette, D Goodridge, ... Chest 147 (4), 894-942, 2015 | 378 | 2015 |
| Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study DS Postma, C Brightling, S Baldi, M Van den Berge, LM Fabbri, ... The Lancet Respiratory Medicine 7 (5), 402-416, 2019 | 362 | 2019 |
amir sharafkhanehProfessor of Medicine, Medical Director of AI in Health, Baylor College of MedicineAdresse e-mail validée de bcm.edu
